Treatment for Social Anxiety
Social anxiety disorder is treatable. The strongest evidence supports psychological treatment developed specifically for social anxiety—particularly individual cognitive behavioral therapy—while medication and several other approaches may also be appropriate depending on age, preference, access, health, and previous response.
Treatment is not meant to turn you into an extrovert, eliminate every anxious feeling, or guarantee approval. It should help you understand what maintains the fear, reduce the restrictions it places on your life, and participate more freely in relationships, work, education, health care, and everyday situations.
Short Answer
For adults with social anxiety disorder, individual CBT specifically developed for social anxiety is the most strongly supported psychological treatment and is recommended first by major guidelines such as NICE. It actively targets feared predictions, self-focused attention, avoidance, safety behaviors, negative self-imagery, and processing before and after social events.
Medication can also reduce symptoms for some adults. SSRIs and SNRIs have the most established medication evidence, but benefits, adverse effects, interactions, discontinuation effects, other health conditions, and personal preference must be discussed with a qualified prescriber.
Other psychological approaches may help, but they do not all have equally strong or equally specific evidence for social anxiety disorder. Treatment format also matters: “group,” “online,” and “self-help” describe delivery, not one uniform intervention.
There is no single best plan for every person. Evidence should guide the choice, but so should age, goals, severity, co-occurring conditions, safety, accessibility, treatment history, culture, and informed preference.
Evidence Snapshot
Systematic reviews and network meta-analyses consistently support CBT for adult social anxiety disorder. Recent evidence continues to favor disorder-specific CBT, while also supporting several delivery formats. Medication reviews support antidepressants—especially SSRIs and the SNRI venlafaxine—as effective options for many adults, although tolerability and response vary.
NICE recommends individual CBT based on the Clark and Wells or Heimberg models as the initial treatment for adults. If an adult declines full CBT, the guideline recommends CBT-based supported self-help; if the person prefers medication, it recommends discussing an SSRI. NICE also includes a social-anxiety-specific short-term psychodynamic treatment for adults who decline both cognitive behavioral and medication options, while noting more limited effectiveness than the preferred options.
Guidelines are not universal rules. They are written for particular health systems and dates, and local approvals and prescribing practices differ. Research averages also cannot predict an individual’s outcome. The most defensible conclusion is that treatment should begin with well-supported options, be delivered competently, be monitored, and be revised when it is not producing meaningful benefit.
See Evidence Standards for how this site distinguishes established treatments, promising approaches, treatment components, and unsupported claims.
Good Treatment Starts With Assessment
Feeling shy or anxious socially does not by itself establish social anxiety disorder. A qualified assessment considers the nature of the fear, avoidance, distress, duration, functional impact, developmental stage, context, and whether another difficulty better explains the symptoms.
A useful assessment may explore:
- feared and avoided situations, including those endured with intense distress;
- the specific outcomes you predict and what those outcomes would mean;
- self-focused attention, mental imagery, physical symptoms, and safety behaviors;
- anticipatory worry and post-event rumination;
- effects on relationships, education, work, finances, health care, and daily functioning;
- depression, panic, trauma symptoms, obsessive-compulsive symptoms, eating difficulties, psychosis, bipolar symptoms, and personality-related difficulties;
- autism, ADHD, learning, speech, language, communication, and sensory differences;
- alcohol, cannabis, sedatives, stimulants, and other substance use;
- medical conditions and medications that may contribute to sweating, shaking, flushing, dizziness, palpitations, or voice changes;
- bullying, abuse, discrimination, exclusion, cultural expectations, and genuine social or occupational risk;
- self-harm, suicide risk, harm from others, and other urgent safety concerns.
Standardized measures such as the SPIN or LSAS can support assessment and track change, but a score is not a complete diagnosis and should not replace clinical judgment.
What if depression or substance use is also present?
Co-occurring problems should not automatically exclude social anxiety treatment. The clinician should clarify how the difficulties relate, which problem creates the greatest immediate risk or impairment, and whether they should be treated together, sequentially, or through coordinated care. Severe depression, withdrawal risk, dependence, mania, psychosis, or acute danger may change what needs attention first.
Treatment Options at a Glance
This comparison summarizes broad evidence and practical differences. Individual programs within each category vary.
| Option | Evidence and guideline position | Important considerations |
|---|---|---|
| Individual disorder-specific CBT | Extensive evidence; commonly recommended as the initial psychological treatment for adults. | Active practice and between-session work are typical. Therapist competence in social-anxiety-specific CBT matters. |
| Group CBT | Established evidence, but NICE does not prefer it over individual CBT for adults. | Offers direct social practice and peer learning; less individual time and the group format may not suit everyone. |
| Guided internet or remote CBT | Good and growing evidence; recent reviews find remote CBT effective. | Programs differ in guidance, assessment, personalization, risk procedures, privacy, and real-world practice. |
| CBT-based supported self-help | Guideline-supported option for some adults who decline full CBT. | Should be structured and supported; may be insufficient when risk, impairment, or complexity is high. |
| SSRIs or SNRIs | Established medication evidence; an option when preferred or when psychological treatment is unavailable or insufficient. | Require prescribing assessment and monitoring; adverse effects, interactions, activation, and discontinuation symptoms are possible. |
| Social-anxiety-specific short-term psychodynamic therapy | Some supportive trial evidence; included by NICE when adults decline CBT and medication, with more limited effectiveness noted. | Generic open-ended supportive work should not be assumed equivalent to the studied protocol. |
| ACT, mindfulness-based, compassion-focused, metacognitive, emotion-focused, and other approaches | Evidence ranges from promising to limited and is generally less extensive or less disorder-specific than CBT. | May fit particular processes or preferences, or be integrated into care. Claims should match the actual evidence for the specific protocol. |
| Social skills training | Often used as a component; not necessary for everyone and less established as a universal stand-alone treatment. | Most relevant when skills are underdeveloped, under-practiced, or blocked—not simply because a person feels anxious. |
Psychological Treatments
Disorder-specific cognitive behavioral therapy
CBT for social anxiety uses a personalized model to address the predictions and behaviors that maintain fear. Established Clark and Wells– and Heimberg-based protocols include combinations of education, attention work, cognitive methods, exposure, behavioral experiments, reduction of safety behaviors, work with beliefs or memories, and relapse prevention.
CBT is not positive thinking or reassurance. Good treatment does not promise that judgment never occurs. It helps test whether threat is being overpredicted, whether protective strategies prevent learning, and whether you underestimate your ability to cope with uncertainty, imperfection, or a negative response.
Exposure and behavioral experiments
These are often components of CBT rather than competing treatments. Exposure means approaching relevant situations in a planned way to create new learning. Behavioral experiments test specific predictions under fair conditions. Neither should be used as punishment, humiliation, coercion, or a demand to remain in genuine danger.
Group therapy
Group CBT can combine structured treatment with direct practice, feedback, and repeated experience of being seen by others. A supportive discussion group is not automatically CBT, however. Ask about the model, facilitator training, group size and composition, confidentiality, between-session practice, and how progress is monitored.
Remote CBT and digital programs
Video therapy and guided internet CBT can improve access and have supportive evidence. A digital program should still be evaluated for clinical assessment, therapist or coach guidance, personalization, security, accessibility, crisis procedures, and whether it supports practice in the person’s actual life. An app using CBT language is not automatically an evidence-based treatment.
Psychodynamic therapy
Psychodynamic therapy may focus on shame, recurring relationship patterns, conflict, self-protection, and expectations of how others will respond. A social-anxiety-specific short-term protocol has trial support, although the overall evidence base is less extensive and guideline estimates are less favorable than for individual CBT.
ACT and mindfulness-informed approaches
Acceptance and Commitment Therapy emphasizes willingness, present-moment awareness, values, and action without waiting for anxiety to disappear. Mindfulness may support attention and a less reactive relationship with internal experience. These ideas can be useful, but broad mindfulness practice or generic acceptance work should not be presented as having the same social-anxiety-specific evidence as established CBT protocols.
Metacognitive, compassion-focused, and emotion-focused work
Metacognitive Therapy focuses on worry, rumination, attention, and beliefs about thinking. Compassion-Focused Therapy may be relevant when shame and self-criticism are prominent. Emotion-Focused Therapy explores emotional patterns and needs. Each has a different rationale and a smaller or less replicated social-anxiety evidence base than CBT; they may be considered according to goals, preference, availability, and clinical judgment.
Social skills training
Social anxiety does not automatically mean poor social skills. Social skills training may help when avoidance has prevented practice, a specific skill is missing, or neurodevelopmental and communication needs call for explicit support. It should not become masking, forced conformity, or performance coaching that leaves fear and shame untouched.
See Other Therapy Approaches for Social Anxiety for additional modalities and a framework for evaluating their claims.
Medication for Social Anxiety
Medication can reduce social anxiety symptoms for some adults. It may be considered because the person prefers it, psychological treatment is inaccessible, symptoms make engagement difficult, a well-delivered therapy has not helped enough, or co-occurring conditions influence the plan. Medication does not teach behavioral or interpersonal skills by itself, but symptom reduction may make participation easier.
Medication decisions require individualized medical care. This page does not recommend a drug or provide dosing advice. A prescriber must consider diagnosis, age, pregnancy, other conditions, current medications and substances, interactions, previous response, adverse effects, overdose risk, and personal preference.
SSRIs and SNRIs
These antidepressant classes have the most established medication evidence for social anxiety disorder. They usually take time to work and can cause adverse effects. Early activation—such as increased anxiety, agitation, jitteriness, or sleep difficulty—can occur. Sexual effects, gastrointestinal symptoms, sleep changes, and other problems are also possible, with risks differing by medication and person.
Antidepressants should not be stopped abruptly without clinical advice. Discontinuation symptoms can occur, and some medications carry a higher risk than others. Monitoring is especially important after starting or changing treatment and when suicide or self-harm risk is present. NICE calls for closer early monitoring in people under 30 who start an SSRI or SNRI; local guidance may differ.
Beta-blockers
Beta-blockers are sometimes prescribed off-label for physical symptoms in circumscribed performance situations. They do not address the broader cognitive and behavioral pattern of social anxiety disorder, and a recent systematic review found insufficient evidence of benefit for anxiety disorders, including social phobia. They can also be unsuitable for some people because of cardiovascular, respiratory, metabolic, or medication-related risks. Discuss use only with a qualified prescriber.
Benzodiazepines and other products
NICE does not recommend routinely offering benzodiazepines, anticonvulsants, tricyclic antidepressants, or antipsychotics for adult social anxiety disorder. Benzodiazepines can produce sedation, cognitive effects, tolerance, dependence, withdrawal, and dangerous interactions with alcohol or other sedating substances. Do not self-treat with someone else’s prescription, alcohol, cannabis, sedatives, supplements, or “natural” products. Natural does not mean effective or interaction-free.
Combining medication and CBT
Combination is not automatically required or superior for everyone. NICE suggests considering medication alongside individual CBT after only a partial response to an adequate CBT course, and adding individual CBT after a partial response to an initial SSRI trial. Sequencing should be individualized and monitored rather than based on the assumption that more treatment is always better.
See Medication for Social Anxiety for a fuller medically cautious overview.
How to Choose a Treatment
A useful decision considers several dimensions together:
Evidence for the actual intervention
Ask about the named protocol, target population, delivery format, and therapist competence—not only the therapy brand. Evidence for one manualized treatment does not automatically apply to every therapist, app, course, or hybrid using the same label.
Your main difficulties and goals
Is the priority broad avoidance, performance fear, dating, blushing, work participation, loneliness, substance use, severe shame, trauma-related memories, or another pattern? A good plan addresses both symptoms and meaningful functioning.
Severity, risk, and co-occurring conditions
Self-help may be reasonable for some people, but severe impairment, self-harm risk, dependence, psychosis, mania, serious depression, an eating disorder, ongoing abuse, or complex medical concerns may require specialist or coordinated care.
Preferences and practical access
Cost, location, waitlists, language, schedule, caregiving, disability access, sensory needs, privacy, internet access, culture, and comfort with group or individual care all matter. A theoretically ideal treatment that cannot be accessed or sustained is not a workable plan.
Benefits, burdens, and uncertainty
Psychological treatment requires time, practice, and willingness to approach discomfort. Medication involves medical monitoring and the possibility of adverse and discontinuation effects. Other approaches may feel more personally fitting but have less certain evidence. Shared decision-making should make these tradeoffs explicit.
Previous treatment
“I tried therapy” may mean very different things: a few supportive sessions, generic anxiety CBT, a complete disorder-specific course, an app, or treatment interrupted by access problems. Before declaring an approach ineffective, clarify what was actually delivered, at what intensity, for how long, and with what outcome.
Treatment for Children and Young People
Treatment recommendations for adults should not simply be copied onto children. NICE recommends individual or group CBT focused on social anxiety for children and young people, adapted to cognitive and emotional maturity. Depending on age and need, treatment may include education, graduated practice in feared situations, social skills work, rehearsal, and involvement of parents or carers.
Assessment should consider school attendance and participation, bullying or ostracism, family and peer environments, selective mutism, developmental and communication needs, neurodevelopmental conditions, depression, substance use, and safeguarding. The young person should have ways to participate even if speaking to an unfamiliar clinician is initially difficult.
NICE advises against routinely offering medication specifically for social anxiety disorder in children and young people. Medication decisions involving a minor require an appropriately qualified child or adolescent clinician and careful consideration of the full clinical picture, local guidance, monitoring, and family involvement where appropriate.
Self-Help, Peer Support, and Lifestyle Measures
High-quality self-help can teach the social anxiety model, help identify avoidance and safety behaviors, and guide structured practice. Supported CBT self-help has more evidence than unguided motivational content. Peer groups can reduce shame and offer encouragement, but peer support is not a substitute for assessment, psychotherapy, prescribing, or crisis care.
Sleep, movement, nutrition, social support, reduced alcohol or stimulant use, and stress management can influence well-being and capacity to engage in treatment. They are supportive foundations, not proven stand-alone treatments for social anxiety disorder. Advice should account for disability, illness, finances, caregiving, culture, and eating-disorder risk rather than becoming another standard of perfection.
Be cautious with programs promising rapid confidence, guaranteed cure, subconscious “reprogramming,” permanent symptom elimination, or secret methods suppressed by mainstream care. Testimonials cannot establish effectiveness, and a high price does not indicate clinical quality.
When the First Treatment Is Not Helping Enough
A limited response does not mean you are untreatable or failed treatment. It signals a need to review the case and the care delivered.
1. Review the diagnosis and formulation
Is social anxiety the main problem? Are depression, trauma, autism, ADHD, substance use, bipolar disorder, psychosis, medical symptoms, or genuine danger changing the picture?
2. Check whether treatment was adequate
Was it disorder-specific, delivered competently, long enough, active enough, and connected to daily-life practice?
3. Identify barriers without blame
Were assignments too large, inaccessible, poorly explained, unsafe, unaffordable, or incompatible with life demands?
4. Use outcome data and functioning
Has there been change in symptoms, avoidance, relationships, work, education, substance use, or quality of life?
5. Revise collaboratively
Options may include adapting or intensifying treatment, addressing a co-occurring problem, changing therapist or modality, adding CBT or medication after partial response, or seeking specialist consultation.
Improvement may continue after treatment, but months of unchanged care without a clear rationale should prompt review. Treatment should not continue indefinitely simply because discussing difficulties feels supportive; support matters, but goals, benefit, and alternatives should remain discussable.
Finding Competent and Safe Care
Licensing and professional titles differ by country. Verify that the provider is appropriately regulated or credentialed for the service they offer, and ask about their actual experience with social anxiety.
Useful questions include:
- How do you assess social anxiety and related conditions?
- Which treatment model or protocol will guide our work?
- What will sessions and between-session practice involve?
- How do you use exposure or behavioral experiments, and how is consent handled?
- How will you adapt treatment for culture, disability, neurodivergence, trauma, or communication needs?
- How will we measure progress and decide whether to change the plan?
- How do you manage privacy, recordings, emergencies, and contact between sessions?
- What are the fees, cancellation rules, expected duration, and alternatives if care becomes unaffordable?
Treatment may be challenging, but it should not be shaming, coercive, discriminatory, sexually or financially exploitative, or dismissive of genuine risk. A clinician should be able to explain the rationale, welcome feedback, obtain informed consent, and discuss limitations.
See How to Choose a Therapist for Social Anxiety for a detailed guide.
What Progress Can Look Like
Progress may involve symptom change, but it should also be visible in life:
- approaching situations that matter rather than organizing life around avoidance;
- participating while anxious instead of waiting for perfect confidence;
- using fewer safety behaviors and relying less on alcohol or reassurance;
- paying more attention to the conversation or task than to self-monitoring;
- ruminating less before and after social events;
- recovering more flexibly from mistakes, awkwardness, criticism, or rejection;
- expressing preferences, warmth, humor, needs, boundaries, and disagreement more freely;
- improving participation in relationships, education, work, health care, or community life;
- responding to setbacks with a plan rather than a global conclusion about yourself.
Anxiety can fluctuate with stress and life events. A difficult week does not erase prior learning. The goal is a broader, more flexible life—not flawless social performance.
When More Immediate Help Is Needed
Seek prompt professional support when social anxiety is accompanied by severe depression, inability to meet basic needs, escalating alcohol or drug use, dangerous withdrawal, self-harm, suicidal thoughts, psychosis, mania, abuse, exploitation, or another urgent concern.
If you may harm yourself or someone else, cannot stay safe, or are in immediate danger, contact local emergency services or an appropriate crisis service now. Use this site’s crisis help page to find options.
Key Takeaways
- Social anxiety disorder is treatable, but treatment should follow an adequate assessment.
- Individual CBT specifically developed for social anxiety has the strongest psychological evidence for adults.
- Group, remote, and supported self-help CBT can be effective, but format and quality vary.
- SSRIs and SNRIs are established medication options for adults and require individualized prescribing and monitoring.
- Other therapies may help, but their evidence is not identical in strength, specificity, or replication.
- For children and young people, developmentally appropriate social-anxiety-focused CBT is recommended; adult medication guidance should not be applied automatically.
- Choice should integrate evidence, goals, risk, comorbidity, accessibility, prior response, and informed preference.
- If treatment is not helping enough, review the diagnosis, formulation, delivery, barriers, and next-step options rather than blaming the person.
Continue Learning
Explore the main treatment options and practical next steps in more detail.
A detailed guide to disorder-specific CBT, its components, evidence, formats, and limitations.
Learn how planned approach practice creates new learning without becoming punishment or flooding.
See how feared predictions can be translated into fair, observable questions.
A medically cautious overview of established options, limitations, monitoring, and safety.
Understand the potential benefits, demands, formats, and markers of a well-run group.
Compare additional approaches without treating all evidence bases as equivalent.
Evaluate credentials, social-anxiety competence, treatment planning, fit, and red flags.
Learn how CSA evaluates research quality and communicates certainty about treatment claims.
References
Archer, C., Wiles, N., Kessler, D., Turner, K., & Caldwell, D. M. (2025). Beta-blockers for the treatment of anxiety disorders: A systematic review and meta-analysis. Journal of Affective Disorders, 368, 90–99. https://doi.org/10.1016/j.jad.2024.09.068
Barkowski, S., Schwartze, D., Strauss, B., Burlingame, G. M., Barth, J., & Rosendahl, J. (2016). Efficacy of group psychotherapy for social anxiety disorder: A meta-analysis of randomized-controlled trials. Journal of Anxiety Disorders, 39, 44–64. https://doi.org/10.1016/j.janxdis.2016.02.005
Hall, M., Luo, A., Bhullar, N., Moses, K., & Wootton, B. M. (2025). Cognitive behaviour therapy for social anxiety disorder: A systematic review and meta-analysis investigating different treatment formats. Australian Psychologist, 60(1), 1–14. https://doi.org/10.1080/00050067.2024.2356804
Leichsenring, F., Salzer, S., Beutel, M. E., Herpertz, S., Hiller, W., Hoyer, J., Huesing, J., Joraschky, P., Nolting, B., Pöhlmann, K., Ritter, V., Stangier, U., Strauss, B., Stuhldreher, N., Tefikow, S., Teismann, T., Willutzki, U., Wiltink, J., & Leibing, E. (2013). Psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: A multicenter randomized controlled trial. American Journal of Psychiatry, 170(7), 759–767. https://doi.org/10.1176/appi.ajp.2013.12081125
Mayo-Wilson, E., Dias, S., Mavranezouli, I., Kew, K. M., Clark, D. M., Ades, A. E., & Pilling, S. (2014). Psychological and pharmacological interventions for social anxiety disorder in adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 1(5), 368–376. https://doi.org/10.1016/S2215-0366(14)70329-3
National Institute for Health and Care Excellence. (2013). Social anxiety disorder: Recognition, assessment and treatment (CG159). https://www.nice.org.uk/guidance/cg159
Sun, L., Dai, X., Zhu, S., Liu, Z., & Zhang, Z. (2025). Psychotherapies for social anxiety disorder in adults: A systematic review and Bayesian network meta-analysis. Journal of Affective Disorders, 378, 301–319. https://doi.org/10.1016/j.jad.2025.02.092
CSA provides educational information—not emergency support or a substitute for professional diagnosis, treatment, or therapy. If you are in immediate danger or experiencing an acute crisis, please contact an appropriate local service without delay. For more information, see Crisis Help and the Medical and Mental Health Disclaimer.